Other
Critically Ill
2
Pipeline Programs↗
8
Active Trials↗
3
Companies Involved↗
Critically Ill is an early-stage landscape with 2 programs across 3 companies. The most active players are Fresenius Kabi Oncology Ltd., AstraZeneca, GSK. 2 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Approved
No programs
Analysis
Trial Status
44
clinical trials
Completed23 · 52%
Recruiting6 · 14%
Unknown status6 · 14%
Terminated4 · 9%
Withdrawn3 · 7%
Not yet recruiting2 · 5%
Clinical Trials
Trial Activity
44 trials
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Recruiting·—·N/A·NCT05055830·2,000 enrolled
Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults
Recruiting·—·Phase 2·NCT04608630·450 enrolled
Transducer Levelling Errors in Everyday ICU Practice - A Multicentre Blinded Observational Study
Recruiting·—·N/A·NCT07330505·60 enrolled
The Association of Vitamin D Supplementation With the Outcome in Critically Ill Children
Completed·—·Phase 4·NCT04536831·96 enrolled
Intravenous Fish Oil in Critically Ill Cardiac Patients
Completed·—·Phase 3·NCT00516178·31 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)